Clinical Trial Update: One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compares one and two doses of oxfendazole to two doses of triclabendazole for chronic fascioliasis; the study status is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fascioliasis

Drugs mentioned

• Oxfendazole (oxfendazole)
• Triclabendazole (Triclabendazole)

Snippet

Sponsor: Universidad Peruana Cayetano Heredia | Conditions: Fascioliasis | Phase 2 | Status: NOT_YET_RECRUITING